Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LEVETIRACETAM | 750MG | TABLET | Resolved | 2023-06-19 | 2023-10-04 | 195484 |
| TEVA-LEVETIRACETAM | 750MG | TABLET | Resolved | 2023-06-08 | 2023-10-04 | 194106 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2023-06-08 | 2023-08-18 | 194103 |
| TEVA-LEVETIRACETAM | 250MG | TABLET | Actual shortage | 2025-02-20 | 2026-01-15 | 250903 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2024-07-04 | 2024-09-19 | 232217 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2025-07-03 | 2025-12-18 | 261791 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195591 |
| TEVA-LEVOCARBIDOPA | 25MG 100MG | TABLET | Actual shortage | 2019-11-28 | 2022-08-18 | 99935 |
| TEVA-LEVOCARBIDOPA | 25MG 100MG | TABLET | Resolved | 2017-04-03 | 2017-11-07 | 5207 |
| TEVA-LEVOCARBIDOPA | 25MG 100MG | TABLET | Resolved | 2019-09-26 | 2019-10-10 | 94864 |
| TEVA-LEVOCARBIDOPA | 25MG 100MG | TABLET | Resolved | 2017-03-14 | 2017-11-07 | 2297 |
| TEVA-LEVOCARBIDOPA | 25MG 250MG | TABLET | Resolved | 2017-08-21 | 2018-02-22 | 19973 |
| TEVA-LEVOCARBIDOPA | 10MG 100MG | TABLET | Actual shortage | 2020-03-26 | 2020-03-26 | 109550 |
| TEVA-LEVOCARBIDOPA | 25MG 100MG | TABLET | Actual shortage | 2019-12-05 | 2022-08-18 | 100299 |
| TEVA-LEVOCARBIDOPA | 25MG 250MG | TABLET | Actual shortage | 2020-02-21 | 2020-03-26 | 106945 |
| TEVA-LEVOCARBIDOPA | 25MG 250MG | TABLET | Resolved | 2017-08-01 | 2018-02-22 | 17896 |
| TEVA-LIOTHYRONINE | 5MCG | TABLET | Resolved | 2021-06-10 | 2021-07-09 | 140684 |
| TEVA-LIOTHYRONINE | 5MCG | TABLET | Resolved | 2021-12-02 | 2022-01-20 | 150400 |
| TEVA-LIOTHYRONINE | 25MCG | TABLET | Actual shortage | 2025-12-11 | 2026-01-22 | 274021 |
| TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Resolved | 2017-03-14 | 2017-05-10 | 2312 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ENALAPRIL | 4MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258682 |
| ACT ENALAPRIL | 8MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258676 |
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2019-02-21 | 2019-03-01 | 76486 |
| ACT FLUCONAZOLE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258697 |
| ACT FLUCONAZOLE | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258703 |
| ACT LEVETIRACETAM | 500MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104304 |
| ACT LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266377 |
| ACT LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266383 |
| ACT LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266380 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
| ACT NABILONE | 1MG | CAPSULE | Discontinued | 2019-10-31 | 2019-11-01 | 97581 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLMESARTAN | 40MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117500 |